CDC34 Antikörper

Produktnummer ABIN6942464

Produktdetails anti-CDC34 Antikörper

Target: CDC34 (Cell Division Cycle 34 (CDC34))

Reaktivität: Human, Maus, Ratte

Wirt: Kaninchen

Klonalität: Monoklonal

Konjugat: Dieser CDC34 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Flow Cytometry (FACS), Immunofluorescence (Cultured Cells) (IF (cc))

Kreuzreaktivität: Human, Maus, Ratte

Aufreinigung: Purified by Protein A.

Immunogen: Full length protein

Klon: 3C2

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB 1:300-5000
FCM 1:20-100
IHC-P 1:200-400
IF(ICC) 1:50-200

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 1xTBS ( pH 7.4), 1 % BSA, 40 %Glycerol and 0.05 % Sodium Azide.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C for 12 months.

Haltbarkeit: 12 months

Details zu CDC34

Target: CDC34 (Cell Division Cycle 34 (CDC34))

Andere Bezeichnung: Cdc34 (CDC34 Produkte)

Synonyme: E2-CDC34 antikoerper, UBC3 antikoerper, UBCH3 antikoerper, UBE2R1 antikoerper, AI327276 antikoerper, e2-cdc34 antikoerper, ubc3 antikoerper, ube2r1 antikoerper, CDC34 antikoerper, DNA6 antikoerper, Ube2r2 antikoerper, zgc:55452 antikoerper, fb34h09 antikoerper, wu:fb34h09 antikoerper, wu:fe17e09 antikoerper, zgc:91847 antikoerper, cell division cycle 34 antikoerper, cell division cycle 34 L homeolog antikoerper, SCF E2 ubiquitin-protein ligase catalytic subunit CDC34 antikoerper, SCF E2 ubiquitin-protein ligase catalytic subunit antikoerper, cell division cycle 34 homolog (S. cerevisiae) a antikoerper, cell division cycle 34 homolog (S. cerevisiae) b antikoerper, CDC34 antikoerper, Cdc34 antikoerper, cdc34.L antikoerper, cdc34 antikoerper, cdc34a antikoerper, cdc34b antikoerper

Hintergrund:

Synonyms: Ubiquitin-conjugating enzyme E2 R1, (E3-independent) E2 ubiquitin-conjugating enzyme R1, E2 ubiquitin-conjugating enzyme R1, Ubiquitin-conjugating enzyme E2-32 kDa complementing, Ubiquitin-conjugating enzyme E2-CDC34, Ubiquitin-protein ligase R1, CDC34

Background: Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. In vitro catalyzes 'Lys-48'-linked polyubiquitination (PubMed:22496338). Cooperates with the E2 UBCH5C and the SCF(FBXW11) E3 ligase complex for the polyubiquitination of NFKBIA leading to its subsequent proteasomal degradation. Performs ubiquitin chain elongation building ubiquitin chains from the UBE2D3-primed NFKBIA-linked ubiquitin. UBE2D3 acts as an initiator E2, priming the phosphorylated NFKBIA target at positions 'Lys-21' and/or 'Lys-22' with a monoubiquitin. Cooperates with the SCF(SKP2) E3 ligase complex to regulate cell proliferation through ubiquitination and degradation of MYBL2 and KIP1. Involved in ubiquitin conjugation and degradation of CREM isoform ICERIIgamma and ATF15 resulting in abrogation of ICERIIgamma- and ATF5-mediated repression of cAMP-induced transcription during both meiotic and mitotic cell cycles. Involved in the regulation of the cell cycle G2/M phase through its targeting of the WEE1 kinase for ubiquitination and degradation. Also involved in the degradation of beta-catenin. Is target of human herpes virus 1 protein ICP0, leading to ICP0-dependent dynamic interaction with proteasomes (PubMed:10329681, PubMed:10373550, PubMed:10871850, PubMed:11675391, PubMed:12037680, PubMed:15652359, PubMed:17461777, PubMed:17698585, PubMed:19112177, PubMed:19126550, PubMed:19945379, PubMed:20061386, PubMed:20347421).

Gen-ID: 997

UniProt: P49427